<--GAT-->

Warfarin Works with Either At-Home or Clinic Testing

by U.S. Medicine

December 14, 2010

WASHINGTON, DC—Patients taking warfarin, a widely used blood-thinning pill that requires careful dose monitoring, have similar outcomes whether they come to a clinic or use a self-testing device at home, according to a recent VA study.  The findings, published in the October 21 issue of the New England Journal of Medicine, are good news for heart patients who live far from clinics or are homebound.

“This study helps answer an important question for cardiologists, primary care physicians, and other health providers, and will lead to improved care for their patients,” explained VA research chief and cardiologist Joel Kupersmith, MD. “The results are significant for a great number of veterans currently receiving care through VA.”

Traditionally, doctors, pharmacists, and nurses monitor patients who are taking warfarin, sold as Coumadin®, over several clinic visits. They test how fast the blood clots and adjust the dose accordingly. Doses that are too low will not prevent dangerous blood clots, and blood flow to the heart, brain, or other areas of the body could be inadvertently blocked. Doses that are too high could lead to dangerous internal bleeding. 

Patients have the option of tracking their own blood response at home, using blood analyzers known as international normalized ratio (INR) monitors. Patients do a finger stick, apply a small amount of blood to a test strip and feed the strip into the device.  The procedure resembles the one used by people with diabetes to check their blood sugar.  Patients can then call in the results to their provider and get advice on dose adjustments without coming to the clinic. In some cases, they can even set the proper dose of warfarin on their own.   

The authors of the VA study expected home monitoring to work better than clinic monitoring, partly because self-testing can be done at home more frequently—weekly, compared with the typical monthly schedule of the best clinic-based monitoring.  As a result, off-target INR values can be adjusted more regularly and more quickly.  

However, the VA study found little difference between weekly self-testing and monthly testing by clinic-based care teams in the measured outcomes, which are strokes, major bleeding incidents, and death.

The study did find, though, that self-testing at home may offer advantages in other areas. It moderately boosted patients’ satisfaction with the medication and slightly increased the length of time they were in the appropriate dose range.  Researchers said the main message of the study is that patients who are systematically monitored—regardless of the means—are likely to have good outcomes.

back to December articles


Comments are closed here.


Related Articles

VA Announces Proposed Standards for Access to Mission Act Outside Care

WASHINGTON—VA has released its proposed new access standards, defining new eligibility criteria for veterans seeking care by non-VA providers. The standards are part of the VA MISSION Act signed into law in June 2018, and... View Article

VA Announces New Partnerships to Expand Telehealth Services

WASHINGTON.—VA Secretary Robert Wilkie announced new partnerships with several prominent companies and veterans’ organizations to make access to health services easier for veterans, regardless of their location. Collaborators announced at the recent Anywhere to Anywhere,... View Article


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

VA Announces Proposed Standards for Access to Mission Act Outside Care

WASHINGTON—Congress announced last month that it will be opening an investigation into alleged improper influence by three civilian consultants to President Donald Trump on administration of the VA. The three men—Ike Perlmutter, CEO of Marvel... View Article

Department of Veterans Affairs (VA)

VA Announces New Partnerships to Expand Telehealth Services

WASHINGTON—Congress announced last month that it will be opening an investigation into alleged improper influence by three civilian consultants to President Donald Trump on administration of the VA. The three men—Ike Perlmutter, CEO of Marvel... View Article

Department of Veterans Affairs (VA)

VA Fails to Use All Outreach Resources to Combat Veteran Suicide

Despite declaring veteran suicide as its No. 1 clinical priority, VA’s suicide prevention outreach efforts dropped off in 2017 and 2018, and a lack of clear goals and inconsistent leadership has impacted its success, according to a Government Accountability Office report.

Department of Veterans Affairs (VA)

Disabled Veteran Helps Others Like Her Get Back Into the Workforce

Ten years ago, Coniece Washington was walking through the Washington, DC, VA Medical Center when she saw a job notice tacked to a board: certified rehabilitation counselor.

Department of Veterans Affairs (VA)

Senate Blocks Agent Orange Exposure Extension to Blue Water Veterans

Blue Water Navy veterans who claim to be impacted by toxic exposure while serving off the coast of Vietnam were forced to grapple with disappointment once again as the 115th Congress ended without passing legislation addressing their VA benefits.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up